Georgia Comprehensive Metabolomics and Proteomics Unit for MoTrPAC
Project Number2U24DK112341-07
Former Number5U24DK112341-06
Contact PI/Project LeaderORTLUND, ERIC A Other PIs
Awardee OrganizationEMORY UNIVERSITY
Description
Abstract Text
Summary
Physical exercise activates a series of molecular events in multiple tissues to meet the demand for
oxygen and substrate. Repetitive exercise causes tissue adaptation and provides broad health benefits. A
fundamental understanding of the molecular mechanisms underlying the beneficial effects of exercise at a
systems level is only beginning to be understood. The Molecular Transducers of Physical Activity Consortium
(MoTrPAC) is an NIH Common Fund initiative created to accelerate the knowledge of exercise biology by
systematically collecting detailed clinical, physiological, and molecular phenotypes in both animal models and in
a racially and ethnically diverse cohort of men and women across the age span. MoTrPAC is a highly integrated
and productive consortium organized into 5 units, each making unique contributions to populating the MoTrPAC
DataHub. MoTrPAc Components include Preclinical Animal Study Sites (PASS), Clinical Centers (CCs), the
Bioinformatics Core (BIC), the Consortium Coordinating Center (CCC) and Chemical Analysis Sites (CAS). This
proposal describes one such CAS, the Georgia Comprehensive Lipidomics Unit for MoTrPAC. Our CAS is
comprised of a team of analytical chemists, lipid biochemists, metabolomicists, systems biologists and
bioinformaticians with expertise in advanced high-throughput chemical analytics and big data, specifically
focusing on exercise-induced alterations of the lipidome.
CAS studies are divided into 3 categories, Genomics/Epigenomics/Transcriptomics, Proteomics, and
Metabolomics/Lipidomics to produce a draft molecular map of exercise. Through the Biospecimens Committee,
a tissue analysis plan (TAP) for both preclinical rats and human tissues was created and approved by the
MoTrPAC Steering Committee. CAS efforts have led to extensive molecular profiles of 6-month and 18-month-
old male and female F344 rats following both exercise training and an acute exercise bout. These data are being
analyzed by teams of MoTrPAC investigators and initial results have been submitted for publication. CAS has
also produced an initial evaluation of blood, muscle and adipose biopsy samples collected from sedentary
participants and those undergoing chronic endurance and resistance exercise training generated by the CC prior
to pause of recruitment due to the SARS-CoV2 pandemic. To complete the MoTrPAC project, CAS investigators
will continue to carry out studies with the following Specific Aims: Aim 1- to participate in consortium-wide
efforts to analyze and publish expansive multiomics data obtained from multiple tissues collected by PASS
investigators; Aim 2- to collaborate with MoTrPAC to implement temporal targeted and untargeted lipidomics
profiling of blood, muscle and adipose tissue according to the TAP; Aim 3- To perform data analysis and transfer
to the BIC through existing pipelines; Aim 4- to participate in MoTrPAC Committees, Subcommittees, and
Working Groups, perform continuous quality assurance of data, develop analytical strategies, and prepare
presentations and manuscripts to disseminate results.
Public Health Relevance Statement
Narrative
Prolonged or intensive physical activity has a profound effect on the lipid profiles of a variety of
organs and bodily fluids. Lipidomics technologies enable these lipid changes to be accurately mapped
to yield a more complete scientific understanding of how exercise affect lipids as fuels, signaling
messengers and structural molecules. We will continue to serve as the MoTrPAC Chemical Analysis
Site devoted to both targeted and untargeted lipidomic studies using mass spectrometry technologies,
and the associated data science and bioinformatic efforts to integrate the multiomic datasets being
created by the Consortium.
NIH Spending Category
No NIH Spending Category available.
Project Terms
18 year oldAccelerationAcuteAdipose tissueAdultAffectAgeAnimal ModelAnimalsBig DataBioinformaticsBiopsy SpecimenBloodBody FluidsCOVID-19 pandemicCategoriesChemicalsChildhoodChronicClinicalCollaborationsCommunicationDataData AnalysesData ScienceData SetElementsEvaluationEventExerciseFemaleFundingGenomicsGoalsHealth BenefitInbred F344 RatsKnowledgeLipidsManuscriptsMapsMass Spectrum AnalysisMolecularMolecular ProfilingMultiomic DataMuscleOrganOxygenParticipantPhysical ExercisePhysical activityPhysiologicalPopulationProductivityProteomicsProtocols documentationPublicationsPublishingQualifyingRattusResearch PersonnelRestScientistSeriesSignal TransductionSiteSystemTechnologyTissuesTrainingTransducersUnited States National Institutes of HealthWomanclinical centercohortdata exchangedata warehouseendurance exerciseepigenomicsethnic diversityexercise interventionexercise traininghuman tissuelipidomelipidomicsmalemenmetabolomicsmolecular phenotypemultiple omicspre-clinicalquality assuranceracial diversityrecruitresistance exercisesedentarysystematic biologytranscriptomicsworking group
National Institute of Diabetes and Digestive and Kidney Diseases
CFDA Code
310
DUNS Number
066469933
UEI
S352L5PJLMP8
Project Start Date
08-December-2016
Project End Date
31-May-2027
Budget Start Date
15-August-2024
Budget End Date
31-May-2025
Project Funding Information for 2024
Total Funding
$387,799
Direct Costs
$304,687
Indirect Costs
$83,112
Year
Funding IC
FY Total Cost by IC
2024
NIH Office of the Director
$387,799
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 2U24DK112341-07
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 2U24DK112341-07
Patents
No Patents information available for 2U24DK112341-07
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 2U24DK112341-07
Clinical Studies
No Clinical Studies information available for 2U24DK112341-07
News and More
Related News Releases
No news release information available for 2U24DK112341-07
History
No Historical information available for 2U24DK112341-07
Similar Projects
No Similar Projects information available for 2U24DK112341-07